New chimeric antimalarials with 4-aminoquinoline moiety linked to a tetraoxane skeleton.
Igor Opsenica, Dejan Opsenica, Charlotte Anne Lanteri, Lalaine Anova, Wilbur K Milhous, Kirsten S Smith, Bogdan A Solaja
Index: J. Med. Chem. 51(19) , 6216-9, (2008)
Full Text: HTML
Abstract
The synthesis of the chimeric molecules consisting of two pharmacophores, tetraoxane and 7-chloro-4-aminoquinoline, is reported. The tetraoxanes 2, 4, and 8 show relatively potent in vitro antimalarial activities, with IC90 values for the Plasmodium falciparum strain W2 of 2.26, 12.44, and 10.74 nM, respectively. In addition, two compounds, 2 and 4, cured mice in a modified Thompson test for antimalarial blood stage activity, with a minimum curative dose of 80 mg/kg, a minimum active dose of 20 mg/kg/day, and a maximum tolerated dose of >960 mg/kg.
Related Compounds
Related Articles:
2008-04-10
[J. Med. Chem. 51(7) , 1995-8, (2008)]
An ELISA test for detecting chloroquine in urine.
1988-01-01
[Trans. R. Soc. Trop. Med. Hyg. 82(2) , 216-20, (1988)]
2012-10-01
[Bioorg. Med. Chem. 20(19) , 5980-5, (2012)]
[J. Chromatogr. A. 345(1) , 209-14, (1985)]
Synthesis, antimalarial activity, and cellular toxicity of new arylpyrrolylaminoquinolines.
2010-09-15
[Bioorg. Med. Chem. 18(18) , 6625-33, (2010)]